Results 131 to 140 of about 1,341 (183)

Antifungal prophylaxis against invasive Candida and Aspergillus infection in adult heart transplant recipients: protocol for a systematic review and meta-analysis [PDF]

Introduction: Invasive fungal infections (IFI) can contribute to increased mortality and morbidity rates after heart transplant in adults. The most common causes are Aspergillus and Candida species.
Irshad, Zahra, Jenkins, Abi, Lim, Hoong Sern, Maidment, Ian D.   +3 more
core   +1 more source

New preparations in systemic fungal infections [PDF]

Introducere Infecțiile fungice sistemice (invazive) reprezintă o problemă medicală și de sănătate publică majoră în ultimele două decenii. S-a estimat că, la nivel global, 1-1,2 miliarde de persoane sunt afectate de fungi, cu aproximativ 1,5 milioane ...
Bacinschi, Nicolae, Catcov, Carolina, Spînosu, Galina   +2 more
core  

Rezafungin in fluconazole-resistant and refractory candidiasis: the first Brazilian experience. [PDF]

Rev Inst Med Trop Sao Paulo
Kruschewsky WLL, Nakagawa JAS, Siqueira LPM, Taborda M, de Oliveira VF, Abdala E, Magri ASGK, Magri MMC.   +7 more
europepmc   +1 more source

Candida auris: an emerging antimicrobial-resistant organism with the highest level of concern

, 2023
Mishra Baishnab, Shyam Kumar , Mishra, SK, Willcox, M , Yasir, M   +3 more
core   +1 more source

Bad to the bone: <i>Candida (Candidozyma) auris</i> vertebral osteomyelitis treated with combination antifungal therapy followed by a novel long-acting echinocandin. [PDF]

ASM Case Rep
Jenkins LB, Christian RL, Karaman BA, Ghannoum MA, Dousa KM.   +4 more
europepmc   +1 more source

The looming threat of invasive fungal infections in heart transplant recipients: Will it be the last of us. [PDF]

JHLT Open
Lowe A, King ST, Hand J.
europepmc   +1 more source

<i>Candida parapsilosis</i> and echinocandins: should the clinical laboratory drop anidulafungin Etest from the susceptibility testing panel? [PDF]

Antimicrob Agents Chemother
Vahedi-Shahandashti R, Moroder E, Lass-Flörl C.   +2 more
europepmc   +1 more source

<i>In vitro</i> activity of novel antifungals, natamycin, and terbinafine against <i>Fusarium</i>. [PDF]

Antimicrob Agents Chemother
Garbe E, Ullah A, Aldejohann AM, Kurzai O, Janevska S, Walther G.   +5 more
europepmc   +1 more source

Studying Candida Biofilms Across Species: Experimental Models, Structural Diversity, and Clinical Implications. [PDF]

Pharmaceuticals (Basel)
Squitieri D, Rizzo S, Torelli R, Mariotti M, Sanguinetti M, Cacaci M, Bugli F.   +6 more
europepmc   +1 more source